Washington University School of Medicine in Saint Louis

St Louis, Missouri 63130

1 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia, Ageusia, Anosmia, Breast Cancer, COVID-19 Pandemic, Covid-19 Pandemic, Covid19, Duchenne Muscular Dystrophy, Heart Disease, Hypogeusia, Hyposmia, Immune Mediated Necrotizing Myopathy

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
• A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma — Completed
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed
• Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) — Stopped early
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) — Completed
• A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) — Completed
• Smell in Covid-19 and Efficacy of Nasal Theophylline — Completed
• Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy — Stopped early
• Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell — Completed
• Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography — Stopped early